Table 2.
Cell line | Tissue | Species | Growth of FeMV-GT2 * |
---|---|---|---|
Fcwf-4 | Whole fetus, macrophage | Felis catus | + + + |
CrFK | Kidney, epithelial | Felis catus | + + |
KE-R | Embryo, fibroblastic | Felis catus | - |
LLC-MK2 | Kidney, epithelial | Macaca mulatta | + + + |
Vero (CCL81) | Kidney, epithelial | Chlorocebus pygerythrus | + |
MA-104 | Kidney, epithelial | Macaca mulatta | - |
MARC-145 | Kidney, epithelial | Macaca mulatta | + |
BHK-21 | Kidney, fibroblastic | Mesocricetus auratus | + |
A9 | Adipose tissue, fibroblastic | Mus musculus | - |
HEK-293 | Kidney, epithelial | Homo sapiens | - |
MDBK | Kidney, epithelial | Bos taurus | - |
MDCK-II | Kidney, epithelial | Canis lupus familiaris | - |
FMN-R | Kidney, epithelial | Microtus arvalis | - |
MGN-R | Kidney, fibroblastic | Myodes glareolus | - |
RAN-2-R | Kidney, epithelial | Rousettus aegyptiacus | - |
FLN-R | Kidney, epithelial | Eptesicus serotinus | - |
* Susceptibility of represented cell lines to FeMV-GT2-Gordon strain infection was semi-quantified after five days p.i. using immunofluorescence staining against FeMV-GT2-nucleoprotein: + + + = ~ 75% FeMV-GT2-positive cells, + + = ~ 50% FeMV-GT2-positive cells, + = ~ 25% FeMV-GT2-positive cells, - = 0% FeMV-GT2-positive cells.